Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Cost of Revenue (2024 - 2025)

Historic Cost of Revenue for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $16.0 million.

  • Beta Bionics' Cost of Revenue rose 6635.56% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.9 million, marking a year-over-year change of. This contributed to the annual value of $37.1 million for FY2024, which is 20930.78% up from last year.
  • Beta Bionics' Cost of Revenue amounted to $16.0 million in Q3 2025, which was up 6635.56% from $15.6 million recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' Cost of Revenue registered a high of $16.0 million during Q3 2025, and its lowest value of $7.7 million during Q1 2024.